Photo taken from Tom Lynch/Twitter
Jul 23, 2024, 07:41
Tom Lynch: Fred Hutchinson Cancer Center expands immunotherapy offerings
Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Centre, shared a post by Tom Lynch, President and Chief Executive Officer at Fred Hutch, on X:
“Excited about the expansion efforts and the future of immunotherapy at Fred Hutch Cancer Centre.”
Quoting Tom Lynch‘s post:
“I look forward to continue working with Mazyar Shadman as we expand Fred Hutchinson Cancer Center’s immunotherapy offerings by minimizing wait times, providing universal access to CAR T cell therapy and bringing the most promising clinical trials to our patients.”
Source: Mazyar Shadman/X and Tom Lynch/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:46
Dec 21, 2024, 13:40
Dec 21, 2024, 13:33
Dec 21, 2024, 13:20
Dec 21, 2024, 13:12